SCHEMBL6892757

SCHEMBL6892757

CCCN(CCC)C(=O)c1cccc(C(=O)N[C@@H](Cc2ccccc2)C(O)C[NH])c1

nearest known ligand 0.73

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
BACE1 P56817 17/20 0.73
CTSD P07339 7/20 0.63
BACE2 Q9Y5Z0 4/20 0.62
APP P05067 2/20 0.57

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6892761 0.90 BACE1 (0.73) BACE1CTSDBACE2APP
SCHEMBL5350048 0.88 BACE1 (0.78) BACE1CTSDBACE2
SCHEMBL5353972 0.87 BACE1 (0.78) BACE1CTSDBACE2
SCHEMBL13307525 0.87 BACE1 (0.86) BACE1CTSDBACE2
SCHEMBL5362382 0.87 BACE1 (0.86) BACE1CTSDBACE2
SCHEMBL5347519 0.86 BACE1 (0.76) BACE1CTSDBACE2
SCHEMBL3352669 0.86 BACE1 (0.76) BACE1CTSDBACE2
SCHEMBL5354272 0.85 BACE1 (0.75) BACE1CTSDBACE2
SCHEMBL3354110 0.85 BACE1 (0.75) BACE1CTSDBACE2
SCHEMBL5348231 0.85 BACE1 (0.75) BACE1CTSDBACE2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
JP-2004502669-A 2004-01-29 JP claimed
EP-1353898-A2 COMPOUNDS TO TREAT ALZHEIMER'S DISEASE Elan Pharmaceuticals, Inc. (US) 2003-10-22 EP claimed
WO-2002002512-A2 COMPOUNDS TO TREAT ALZHEIMER'S DISEASE ELAN PHARMACEUTICALS, INC. (US) 2002-01-10 WO claimed